GSTC (GlobeStar Therapeutics) Total Operating Expense: $0.81 Mil (TTM As of Jun. 2024)


What is GlobeStar Therapeutics Total Operating Expense?

GlobeStar Therapeutics GSTC -99.00% Total Operating Expense is $0.81 Mil as of Jun. 2024.

GlobeStar Therapeutics's Total Operating Expense for the three months ended in Jun. 2024 was $0.19 Mil. GlobeStar Therapeutics's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was $0.81 Mil.

GlobeStar Therapeutics Total Operating Expense Related Terms

GlobeStar Therapeutics Total Operating Expense Historical Data

* Premium members only.

The historical data trend for GlobeStar Therapeutics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlobeStar Therapeutics Total Operating Expense Chart

GlobeStar Therapeutics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.27 9.09 1.27 1.86

GlobeStar Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 0.29 0.16 0.17 0.19

GlobeStar Therapeutics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.81 Mil mean?
GlobeStar Therapeutics (GSTC) has a Total Operating Expense of $0.81 Mil as of Jun. 2024. Total operating expense is the primary recurring expense associated with central operations. View historical data on GlobeStar Therapeutics and its competitors.
Is GlobeStar Therapeutics' Total Operating Expense too high?
GlobeStar Therapeutics' current Total Operating Expense is $0.81 Mil.
How does GlobeStar Therapeutics' Total Operating Expense compare to GBLX and ENDV?
GlobeStar Therapeutics' Total Operating Expense of $0.81 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on GlobeStar Therapeutics and its competitors. GlobeStar Therapeutics's current Total Operating Expense is $0.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlobeStar Therapeutics stock overvalued right now?
GlobeStar Therapeutics (GSTC) has a current Total Operating Expense of $0.81 Mil. The current Total Operating Expense is $0.81 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For GlobeStar Therapeutics (GSTC), the current Total Operating Expense is $0.81 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlobeStar Therapeutics Business Description

Address 719 Jadewin Avenue, Richland, WA, USA, 99352
GlobeStar Therapeutics Corp is a clinical-stage pharmaceutical company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.